COMMUNIQUÉS West-GlobeNewswire

-
Abeona Therapeutics annonce des données intermédiaires positives provenant de l'essai clinique de phase 1/2 sur la thérapie génique ABO-102 dans la MPS III A
26/07/2019 -
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
26/07/2019 -
Avinger to Announce Second Quarter 2019 Financial Results on July 31, 2019
26/07/2019 -
Generex Biotechnology Provides a Summary of Its Investor Conference Call Held on July 25, 2019
26/07/2019 -
SeaSpine Announces 20,000th NanoMetalene® Implantation
26/07/2019 -
Novartis receives positive CHMP opinion for Lucentis® treatment in preterm infants with retinopathy of prematurity (ROP), a disease causing visual impairment and blindness
26/07/2019 -
Avid Bioservices Announces Appointment of Catherine Mackey, Ph.D. to Board of Directors
26/07/2019 -
Operational Update
26/07/2019 -
Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union
26/07/2019 -
Theratechnologies reçoit une recommandation positive du CHMP pour le Trogarzo(MD) dans l’Union européenne
26/07/2019 -
T2 Biosystems Expands Global Access to its Innovative Rapid Diagnostic Technologies
26/07/2019 -
Solid Biosciences Announces $60 Million Private Placement with New and Existing Investors
26/07/2019 -
Roche receives CHMP positive opinion for new Tecentriq-based combination therapy as an initial treatment for most common form of advanced lung cancer
26/07/2019 -
CHMP recommends EU approval of Roche’s Tecentriq in combination with chemotherapy as an initial treatment of adults with extensive-stage small cell lung cancer
26/07/2019 -
Stockholm Patent and Market court resolution of dispute over C-RAD’s claim for Beamocular patent
26/07/2019 -
Axogen Announces Publication of the 100th Peer-Reviewed Clinical Paper Featuring its Product Portfolio for Peripheral Nerve Repair
26/07/2019 -
Iovance Biotherapeutics to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Thursday, August 1, 2019
26/07/2019 -
GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX™ (cannabidiol oral solution) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy
26/07/2019 -
GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX™ (cannabidiol oral solution) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy
26/07/2019
Pages